Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Smith, J. B.
space
  arrow  Haynes, M. K.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

Rheumatoid Arthritis—A Molecular Understanding

right arrow J. Bruce Smith, MD, and Mark K. Haynes, PhD

18 June 2002 | Volume 136 Issue 12 | Pages 908-922

The application of molecular immunology techniques in the study of rheumatoid arthritis has resulted in an explosion of knowledge on the risk factors for the disease, predictors of disease severity, the molecular mechanisms of inflammatory responses, and mechanisms of tissue destruction. We know, for example, that inheriting certain genes in the major histocompatibility complex partly dictates susceptibility and severity of rheumatoid arthritis. These genes and others in the major histocompatibility complex are critical for the occurrence of immune responses both constructive (prevention of infection, surveillance for malignant cells) and destructive (development of autoimmune diseases). We also now understand mechanisms of cell communication, regulation of immune responses, how the cells that mediate immune responses and tissue injury accumulate in tissues, and how the injury occurs. The knowledge itself is satisfying, but more important, based on this knowledge, effective and reasonably safe treatments that address basic mechanisms of the disease process have been developed and are now widely used. In fact, the newer treatments represent the "tip of the iceberg," and as our basic knowledge increases, so too will the armamentarium with which we can fight rheumatoid arthritis and other similar autoimmune diseases.

For definitions of terms, see Glossary at end of text.

Author and Article Information
space

From Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.

Acknowledgments: The authors thank Drs. John Abruzzo, Pam Norton, Andrew Koenig, and Stacy Fitch for their careful review and helpful suggestions in the preparation of this manuscript.

Grant Support: By the Mona Schneidman Foundation.

Requests for Single Reprints: J. Bruce Smith, MD, Jefferson Medical College, 613 Curtis Building, Philadelphia, PA 19107.

Current Author Addresses: Dr. Smith: Jefferson Medical College, 1015 Walnut Street, Suite 613–Curtis Building, Philadelphia, PA 19107.

Dr. Haynes: Jefferson Medical College, 1015 Walnut Street, Philadelphia, PA 19107.




This article has been cited by other articles:


Home page
Toxicol SciHome page
J. M. Hansen, H. Zhang, and D. P. Jones
Mitochondrial Thioredoxin-2 Has a Key Role in Determining Tumor Necrosis Factor-{alpha}-Induced Reactive Oxygen Species Generation, NF-{kappa}B Activation, and Apoptosis
Toxicol. Sci., June 1, 2006; 91(2): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
L. C. Huber, O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap
Synovial fibroblasts: key players in rheumatoid arthritis
Rheumatology, June 1, 2006; 45(6): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
T. Doan and E. Massarotti
Rheumatoid Arthritis: An Overview of New and Emerging Therapies
J. Clin. Pharmacol., July 1, 2005; 45(7): 751 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Karlsson, M. Johannesson, T. Lindvall, P. Wernhoff, R. Holmdahl, and A. Andersson
Genetic Interactions in Eae2 Control Collagen-Induced Arthritis and the CD4+/CD8+ T Cell Ratio
J. Immunol., January 1, 2005; 174(1): 533 - 541.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Gause
Progress in the treatment of rheumatic disease
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 13 - 16.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2002 by the American College of Physicians.